Do Clinicians Want Recommendations?

Healthy Individuals (Clinicians) Clinical Trial

Official title:

Do Clinicians Want Recommendations? A Randomized Trial Comparing Evidence Summaries With and Without Evidence Based Recommendations

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02006017
• Other study ID #: 13-480
• Status: Completed
• Phase: N/A
• First received: November 19, 2013
• Last updated: August 31, 2017
• Start date: September 30, 2013
• Est. completion date: August 30, 2017

Study information

• Verified date: August 2017
• Source: McMaster University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The use of the best evidence available for decision-making is nowadays an undisputed goal in health care. However, this is not always achieved in the context of clinical practice. Two of the potential solutions to bridge the gap between evidence and the clinical practice are the "evidence summaries" and the "evidence based recommendations". However, it is not clear, and frequently controversial, to what extent clinicians consider helpful recommendations accompanying evidence summaries. The investigators will explore this question by conducting a study where clinicians will be randomized to receive a clinical scenario accompanied by an evidence summary plus a recommendation and a second clinical scenario accompanied by only for an evidence summary (group A) or vice versa (Group B). The outcome will be clinicians' preferences.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 467
• Est. completion date: August 30, 2017
• Est. primary completion date: August 30, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Were trained as Medical Doctors

• Practice primary care or general internal medicine.

Exclusion Criteria: none

Related Conditions & MeSH terms

• Healthy Individuals (Clinicians)

Intervention

Other:
• Evidence summary alone plus a recommendation

• Evidence summary alone

Locations

Country	Name	City	State
Canada	McMaster University	Hamilton	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Preferences	Preference: for the evidence summary plus the accompanying recommendation or for the evidence summary alone. We will assess this outcome with a 7-point Lickert scale This outcome will be assessed after the presentation of the two clinical scenarios.	Immediately after the intervention (Survey)
Secondary	Understanding	Understanding: Percentage of correct answers regarding the understanding of the evidence: understanding of baseline risk, risk difference, confidence interval and quality of the evidence assessment.	Immediately after the intervention (Survey)
Secondary	Interpretation of benefits and harms	Interpretation of benefits and harms: Distribution of the interpretation of the magnitude of the benefits in comparison with harms	Immediately after the intervention (Survey)
Secondary	Intended course of action	Intended course of action: For the clinical questions related with strong recommendations, we will compare the percentage of appropriate decisions (i.e. decisions that match the strong recommendation).	Immediately after the intervention (Survey)